BUENA, N.J., Jan. 10, 2017
BUENA, N.J., Jan. 10, 2017 /PRNewswire/ -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the 35th Annual J.P. Morgan Healthcare Conference. The Conference is taking place on January 9-12, 2017 at the Westin St. Francis Hotel, San Francisco, CA.
Jason Grenfell-Gardner, President and CEO and Jenniffer Collins, Chief Financial Officer of Teligent, Inc. will present on Wednesday, January 11, 2017 at 12:00 p.m. PST.
The presentation will be webcast and will be accessible online on the investors section of the Company's website at http://www.teligent.com. A replay will be available for 30 days.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.
Contact: Jenniffer Collins
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/teligent-inc-to-present-at-35th-annual-jp-morgan-healthcare-conference-on-january-11-2017-300388104.html
SOURCE Teligent, Inc.